IL17A and neoplasm: Several studies have shown that IL-17 impairs immune surveillance and promotes angiogenesis and carcinogenesis in tumors [1], [29], suggesting that the inflammation environment driven by levels of endogenous IL-17 may contribute to tumor progression.